JSM 2012 Online Program
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Online Program HomeActivity Details
|
|||
228 * ! | Mon, 7/30/2012, 2:00 PM - 3:50 PM | CC-Room 29C | |
Implementing Bayesian Methods in Drug Development — Topic Contributed Papers | |||
Section on Bayesian Statistical Science , Biopharmaceutical Section , Biometrics Section | |||
Organizer(s): Fanni Natanegara, Eli Lilly and Company | |||
Chair(s): Fanni Natanegara, Eli Lilly and Company | |||
2:05 PM | Use of Bayesian Methods to Assess Probability of Achieving Critical Success Factors (CSFs) in Clinical Trials — Cory Heilmann, Eli Lilly and Company | ||
2:25 PM | Bayesian Implementations in Drug Development: Why Progress Is Slow — Beat Neuenschwander, Novartis Pharma | ||
2:45 PM | Implementing Bayesian Methods in Biological Product Development: Regulatory Perspective and Experience — Boguang Zhen, FDA/CBER | ||
3:05 PM | Discussant: John W. Seaman, PhD, Baylor University | ||
3:25 PM | Discussant: Heinz Schmidli, Novartis Pharma AG | ||
3:45 PM | Floor Discussion |
2012 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.